COVID-19 vaccines

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
COVID-19 Vaccine

Coronavirus disease 19 or coronavirus has a range of different vaccines available, and the vaccines work using many different methods including old, well-established technologies like inactivated vaccines, newer viral vector vaccines, and mRNA engineering vaccines.

Vaccine approvals[edit | edit source]

Some COVID-19 vaccines are now fully approved in certain countries, some approved for emergency use only after clinical trials, and a few COVID vaccines only permitted for experimental use (generally limited to Russia, parts of Eastern Europe, and parts of Asia). COVID-19 vaccines are designed to protect against the virus that causes COVID-19, preventing COVID-19 will also provide protection against Long COVID because it is only caused by COVID-19.[1]

ME/CFS[edit | edit source]

About five months after receiving their first or only shot of Covid-19 vaccine, 19% of survey participants with ME/CFS indicated their health had worsened, 9% reported that it had improved and 73% responded that it had not changed. 

This compares to 4% of controls (people who did not have ME/CFS) who said their health had worsened, 7% who indicated it had improved and 89% who reported it had not changed.

ME/CFS advice from specialists[edit | edit source]

Immunocompromised people[edit | edit source]

People with ME/CFS have immune system dysfunction, but are not considered immunocompromised, instead many may have an overactive immune system.[citation needed]

People who are regarded as immunocompromised, such as those living with HIV, or who are immunosuppressed, such as whole organ or stem cell transplant or who are taking immunosuppressants are as significantly greater risk of severe illness from COVID-19, and they do not need to automatically avoid COVID-19 vaccination; the Pfizer/BioNTech, AstraZeneca/Oxford, and Moderna vaccines have been approved for use in these patients in the UK and none of these contain any active or live SARS-CoV-2 virus particles.[2]

Vaccines work better in people who are not immunocompromised or immunosuppressed, but these people are likely to achieve a lower lower of protection against COVID-19.[2] The British Society for Immunology recommend that immunocompromised and immunosuppressed people get a COVID-19 vaccine, and to have both doses, since this will still give some protection against COVID-19, and will help protect them from becoming seriously ill.[2]

People with stable HIV took part in the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccine trials, although in general there is limited information on safety and efficacy of COVID-19 vaccines for immunocompromised and immunosuppressed people.[2]

Immosuppressants that may be used in people with ME/CFS include cyclophosphamide (a nitrogen mustard), dexamethasone, hydrocortísone, prednisolone and rituximab.[3][4]

See also[edit | edit source]

Learn more[edit | edit source]

Allergies and MCAS[edit | edit source]

Immunosuppressant therapy and COVID-19 vaccines[edit | edit source]

General COVID-19 vaccine information[edit | edit source]

References[edit | edit source]

  1. "Information on Vaccination Against SARS-CoV-2" (PDF). American College of Rheumatology. March 2021.
  2. 2.0 2.1 2.2 2.3
  3. "List of Immunosuppressants" (PDF). HSE (Ireland). Retrieved March 17, 2021.
  4. "Immunosuppressive Agents". DrugBank Online. Retrieved March 17, 2021.